We initially examined fasting serum gastrin concentrations in patients who had no known risk factors for hypergastrinaemia (gastrinoma, PPI use, H. pylori infection or atrophic gastritis). The gene discussed is GAST; the disease is gastrin-producing neuroendocrine tumor.